Latest1 information on COVID-19
©2022 Stanford Medicine
Recruiting
I'm InterestedTrial ID: NCT04568122
Rapid Turnaround, Home-based Saliva Testing for COVID-19
Associate Dean, School of Medicine, Roger and Joelle Burnell Professor of Genomics and Precision Health, Professor of Medicine (Cardiovascular Medicine), of Genetics, of Biomedical Data Science and, by courtesy, of Pathology
Inclusion Criteria:
- Hospitalized patients
- Hospitalized at Stanford Health Care for COVID-related complications and tested
positive for SARS-CoV-2 with a PCR-based test
- Able to understand and consent to study and with a clinical trajectory likely to
be consistent with multi-day participation
- High-risk/positive population
- Seeking testing for suspected COVID or a participant in a study of COVID-positive
outpatients
- Own an internet-enabled phone or device capable of loading web pages, receiving
text messages, and taking/uploading photos.
- Willing to participate in the study for 6 months
- Low-risk population
- Own an internet-enabled phone or device capable of loading web pages, receiving
text messages, and taking/uploading photos.
- Willing to participate in the study for 6 months
Exclusion Criteria:
- All participants:
- Participants with salivary gland dysfunction (including patients with Sjogren's
disease or those with xerostomia associated with lupus or rheumatoid arthritis)
- Participants will not be eligible if they identify any reason they are unable to
participate in the study
- High-risk/positive population
- Participants who have color blindness
- Participants unable to operate the SnapDx device
- Low-risk population
- Participants with prior confirmed SARS-CoV-2 infection
- Participants who have color blindness
- Participants unable to operate the SnapDx device
device: Saliva test kit
Recruiting
I'm Interested
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Study Team
650-374-0085